Indegene Sets IPO Price Band At Rs 430-452 Per Share
The IPO consists of a mix of fresh issuance of equity shares worth Rs 760 crore and an offer-for-sale of 2,39,32,732 equity shares by the existing shareholders.
Indegene Ltd. has set the price band for its initial public offering at Rs 430-452 per share.
The digital-first commercialisation-focused company, which focuses exclusively on the global life sciences industry, will launch its initial public offering on May 6. The IPO will close on April 8, with bidding for anchor investors taking place on May 3.
The IPO consists of a mix of fresh issuance of equity shares worth Rs 760 crore and an offer-for-sale of 2,39,32,732 equity shares by the existing shareholders.
Business
The company provides solutions that enable biopharmaceutical, emerging biotech and medical device companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner.
The portfolio of solutions covers all aspects of the commercial, medical, regulatory and R&D operations of life sciences companies.
The technological expertise primarily involves converting unstructured clinical data and information into structured content and analytics-ready data sets. Using such data sets, they can create scientific, medical and promotional content, accelerate patient recruitment for clinical trials, and deliver personalised omnichannel experiences to physicians and patients.
